眶部MRI用于诊断巨细胞动脉炎相关前部缺血性视神经病变
这项前瞻性单中心研究纳入18例近期起病的前部缺血性视神经病变(AION)患者,评估眶部MRI鉴别动脉炎性AION(A-AION)与非动脉炎性AION(NA-AION)的价值。结果显示球后脂肪强化最具鉴别力,敏感度100%(95%CI 72-100)、特异度89%(95%CI 52-100),提示眶部MRI可辅助快速鉴别以指导治疗。
要点
- 球后脂肪强化鉴别A-AION与NA-AION的敏感度100%、特异度89%。
- 神经周围脂肪强化在A-AION组占90.9%,NA-AION组占22.2%(p=0.005)。
- A-AION患者中超过半数未受累对侧眼也可见双侧眶部强化。
核心结论
- 眶部MRI可能帮助临床医生快速鉴别A-AION与NA-AION,从而给予最合适的治疗。
研究设计与样本
- 前瞻性单中心研究,纳入2021年6月至2024年10月间年龄>50岁、近期起病的AION患者,最终诊断经综合评估及≥6个月随访确认。
- 眶部MRI由两名对临床诊断不知情的经验丰富放射科医生独立评估。
主要发现
- 共分析18例患者,9例为A-AION(其中2例双侧受累),9例为NA-AION。
- 眼动脉强化在A-AION组为72.7%、NA-AION组为22.2%(p=0.07)。
- 神经周围脂肪强化在A-AION组为90.9%、NA-AION组为22.2%(p=0.005)。
- 球后脂肪强化在A-AION组为100%、NA-AION组为11.1%(p<0.001)。
- 球后脂肪强化鉴别A-AION的敏感度为100%(95%CI 72-100),特异度为89%(95%CI 52-100)。
临床怎么用
- 对近期起病的AION患者,眶部MRI球后脂肪强化有助于快速区分A-AION与NA-AION。
- A-AION需尽快启动糖皮质激素以预防不可逆视力丧失,而NA-AION无需此类治疗。
局限性
- 研究为单中心、样本量小(共18例),结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Acute anterior ischaemic optic neuropathy (AION) is a feared ischaemic complication of giant cell arteritis (GCA). However, distinguishing arteritic AION (A-AION) from its non-arteritic counterpart (NA-AION), which accounts for approximately 90% of cases, can be challenging. Rapid initiation of glucocorticoids is essential to prevent irreversible vision loss in GCA but is unnecessary in NA-AION. This study evaluated the use of orbital MRI in differentiating A-AION from NA-AION. METHODS: In this prospective single-centre study, patients >50 years who had recent-onset AION were enrolled between June 2021 and October 2024. The final diagnosis of GCA was confirmed after comprehensive assessments and ≥6 months follow-up. Orbital MRIs were independently evaluated by two experienced radiologists blinded to the clinical diagnosis. RESULTS: Of the 18 patients analysed, nine had A-AION (two with bilateral involvement), while nine had NA-AION. MRI demonstrated differences between the groups, notably in contrast enhancement of the ophthalmic artery (72.7% vs 22.2%; p=0.07), perineural fat (90.9% vs 22.2%; p=0.005) and retrobulbar fat (100% vs 11.1%; p<0.001). The most discriminative MRI feature was retrobulbar fat enhancement, achieving 100% (95% CI 72 to 100) sensitivity and 89% (95% CI 52 to 100) specificity. Bilateral orbital enhancement was identified in more than half of the unaffected contralateral eyes in A-AION patients. CONCLUSION: These results suggest that orbital MRI may help clinicians rapidly differentiate between A-AION and NA-AION to provide the most appropriate treatment.
引用
- Brenac G, Bernard A, Lemogne B, et al. Orbital MRI for diagnosing giant cell arteritis in cases of anterior ischaemic optic neuropathy. RMD Open. 2026. PMID: 41730612. doi:10.1136/rmdopen-2025-006370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。